1. Home
  2. NA vs CPHI Comparison

NA vs CPHI Comparison

Compare NA & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NA

Nano Labs Ltd

HOLD

Current Price

$1.93

Market Cap

43.4M

Sector

Technology

ML Signal

HOLD

Logo China Pharma Holdings Inc.

CPHI

China Pharma Holdings Inc.

HOLD

Current Price

$1.04

Market Cap

46.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NA
CPHI
Founded
2019
N/A
Country
China
China
Employees
N/A
221
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.4M
46.5M
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
NA
CPHI
Price
$1.93
$1.04
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
13.5K
1.4M
Earning Date
03-30-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,144,268.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.58
$0.38
52 Week High
$6.30
$19.19

Technical Indicators

Market Signals
Indicator
NA
CPHI
Relative Strength Index (RSI) 52.31 47.61
Support Level $1.64 $0.54
Resistance Level $1.96 $1.43
Average True Range (ATR) 0.09 0.09
MACD 0.01 -0.04
Stochastic Oscillator 81.25 7.50

Price Performance

Historical Comparison
NA
CPHI

About NA Nano Labs Ltd

Nano Labs Ltd is a Web 3.0 infrastructure and product solution provider, as well as a crypto treasury company. It is focused on the development of HTC chips and HPC chips. In addition, the company has established BNB value investment and adopted BNB (a crypto token) as the primary reserve asset. Furthermore, it has launched the iPollo Claw, a dedicated hardware solution for the OpenClaw AI Agent Ecosystem. Nano Labs derives revenue mainly from its HTC and HPC offerings, which comprise Darkbird series HPC chips that feature high performance and high energy consumption efficiency, and Cuckoo series chips, used in GPUs. Geographically, the company generates maximum revenue from the People's Republic of China (PRC), and the rest from Singapore, Hong Kong, the United States, and other markets.

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.

Share on Social Networks: